RSRadwa Shamma

Radwa Shamma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Radwa Shamma has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Walaa Abdelfattah

    Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

    3 shared publications
  • Magd Ahmed Kotb

    Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt

    2 shared publications
  • Nora Badawi

    Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt

    2 shared publications
  • Abeer Aboalazayem

    Cairo University, Faculty of Medicine (Kasr Al-Ainy), Cairo, Egypt; Paediatric Surgery Section/Units, Cairo University Hospitals, Cairo University Specialized Pediatric Hospital (CUSPH) and Cairo University Children's Hospital (Abu El-Reesh El-Mounira). 1 Aly Pacha Ibrahim Street (CUSPH), 4th Floor, Kasr Al-Ainy Region, Cairo, 11451, Egypt

    1 shared publication
  • Ahmad Badr

    Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt

    1 shared publication
  • Ahmed Helmy

    Sohag General Hospital, Ministry of Health and Population, Sohag, Egypt

    1 shared publication

Latest Publications

  • Open Access

    Impact of telemonitoring on glycemic control and quality of life in pediatric patients with type 1 diabetes, single center interventional control study

    by Lubna Fawaz, Nora Badawi, Mostafa Hasan, Radwa Shamma

    Telehealth initiatives offer valuable alternatives for enhancing diabetes management and clinician-patient engagement. This study compared two diabetes education approaches for glycemic outcomes: standard method includes regular physical visits at outpatient clinic versus telemonitoring. We conducted an interventional trial involving 140 pediatric patients with Type 1 diabetes (T1D), who were equally randomized into a telecounseling group (Intervention group, n = 70) and a standard care group (Control group, n = 70). Participants in Intervention group received weekly telephone consultations from diabetes educators, during which glucose records, dietary patterns, and insulin dose adjustments were reviewed. Control group received diabetes education during routine outpatient clinic visits. Both groups were followed up initially at the start of the study and at 6 months. Socioeconomic status and quality of life (QoL) were assessed in all participants. Glycemic control differed significantly between groups. Mean HbA1c values were 8.21 ± 1.82 SDS (Intervention group) versus 9.25 ± 2.22 SDS (Control group). Diabetic ketoacidosis (DKA) episodes were higher in Control group (18%) vs. (1.7%) in Intervention group, p = 0.001. Complication rates (lipodystrophy, proteinuria, dyslipidemia) were elevated in Control group (37.7%) vs. (15.5%) in Intervention group, p = 0.01. Intervention group demonstrated significantly improved QoL scores (p = 0.002). The telemedicine strategy helped to achieve significantly greater HbA1c reductions and fewer diabetes-related complications versus conventional care.

  • Open Access

    Impact of tailored diabetes education on adherence and glycemic control in children and adolescents on continuous subcutaneous insulin infusion, prospective interventional study in a tertiary center

    by Mona Hassan, Mahmoud ElHelaly, Nora Badawi, Mariam Nader, Radwa Shamma

    Background: Structured diabetes education plays a crucial role in the management of Type 1 Diabetes (T1D), especially with advanced technologies such as continuous subcutaneous insulin infusion (CSII). This study evaluates the impact of tailored education on adherence and glycemic control among pediatric CSII users. Patients and methods: This interventional analytical study included 30 patients diagnosed with T1D with age ranged from 5 to 18 years, recruited from Diabetes & Endocrinology Clinic at tertiary university-based children’s hospital. Patients were recruited for one year duration. Patients who were on multiple daily injection (MDI) for 2 to 10 years were shifted to CSII after receiving comprehensive diabetes education. Their education level was assessed individually using a questionnaire to assess patients’ knowledge and application skills at the time of insulin pump insertion, 3 and 6 months later. Twenty-five patients were on mini-med 715, 10 patients used flash glucose monitoring, and 15 patients used self-monitoring blood sugar, while five patients were on mini-med 780G and continuous glucose monitoring (CGM) using guardian 4 (G4). Results: Study included 19 females (63.3%) and 11 males (36.7%) with age ranged from 7 to 11 with mean ± SD of 10.74 ± 1.86. Patients’ education level was assessed before pump insertion, and 3 months later which shows significant improvement in patients’ diabetes knowledge and technical skills with P-value 0.038. Also, time in range (TIR) improved significantly in well-educated patients at 3 and 6 months with P-values 0.048 and 0.025 respectively. There was highly significant improvement of HbA1c after 6 months (8.82 ± 1.5 vs. 7.18 ± 0.56) with P-value 0.000 after receiving diabetes education. Conclusions: Tailored diabetes education significantly improves adherence and glycemic outcomes in pediatric patients using CSII. Integrating structured educational programs with diabetes technology is essential to achieve optimal metabolic control in youth.


  • Open Access

    Association between systemic lupus erythematosus and autoimmune thyroid dysfunction in pediatric population: a single center experience

    by Radwa Ahmed Shamma, Hend Mehawed Soliman, Walaa Abdelfattah, Marwa Ahmed Badawy, Eman Shafik Shafie

    Background: Systemic Lupus Erythematosus (SLE) patients are more likely than the general population to suffer from thyroid illness. The major goal was to assess the thyroid dysfunctions due to immunological factors in Egyptian SLE children and how they are related to the course and severity of the illness. Methods: Fifty children and adolescents with SLE are included in this cross-sectional observational study. Every patient underwent a thorough physical examination and a comprehensive history taking. An enzyme-linked immunosorbent assay (ELISA) approach was used to evaluate the thyroid profile, anti-thyroglobulin (Anti-TG), and anti-thyroid peroxidase (anti-TPO) antibodies. Results: Of the 50 patients, the female: male ratio (F: M = 7:1) was 44 females and 6 males (12%). They were between the ages of 5 and 17. Out of the patients, thirty-two (64%) had thyroid dysfunctions, 19 (38%) had euthyroid sick syndrome, ten (20%) had overt hypothyroidism, three (6%) had subclinical hypothyroidism, and none had hyperthyroidism. Of the 50 patients, one (2%) had increased anti-TPO, whereas all other patients had normal anti-TG levels. A statistically significant negative correlation (p-value 0.007) was seen between the disease duration and free thyroxine (FT4). Furthermore, a significant negative correlation (p-values 0.015 and 0.028) was found when comparing the disease duration with thyroid antibodies (anti-TG and anti-TPO). Conclusion: In Juvenile Systemic Lupus Erythematosus (JSLE), thyroid dysfunctions can be identified. The disease duration but not its activity was significantly correlated with thyroid antibodies. For children with JSLE, thyroid function testing should be done on a regular basis. It is preferable to carry out additional thyroid antibody tests when necessary.


  • Assessment of the Effect of Timing of Insulin Glargine Administration (Bedtime versus Morning) on Glycemic Control in Children with Type 1 Diabetes in Cairo, Egypt: A Single Centre Experience

    by Marise Abdou, Radwa A. Shamma, Ghada M. Anwar, Noha Musa, Marwa F. Mira

    Background: Diabetes control without developing hypoglycemia is challenging in Type 1 diabetes (T1D) management, with few studies evaluating the effect of insulin glargine timing on glucoregulation. Objectives: The aim is to compare glycemic control using continuous glucose monitoring (CGM) in children with T1D receiving bedtime versus morning glargine and to assess CGM effect on glycemia. Methods: This cross-sectional observational study was conducted on 30 pediatric patients with T1D receiving glargine (19 at bedtime and 11 in the morning). CGM sensor was applied for 3-5 days using the I-Pro2 blood glucose sensor. Results: Total daily dose of glargine showed a significant correlation with HbA1C (p=0.006) and percentage of glucose readings within average (p=0.039). HbA1C correlated significantly with time in range (TIR) (p=0.049). Nocturnal hypoglycemia was significantly higher in the bedtime glargine group than in the morning one (p=0.016). The morning glargine group showed better control in terms of lower HbA1C and higher TIR, but these did not reach statistical significance. Follow- up after 3 months revealed significant improvement in the percentage of hyperglycemia, BG readings within average, as well as HbA1c (p:0.001). Conclusions: Bedtime glargine administration was associated with a higher frequency of occurrence of nocturnal hypoglycemia. No statistically significant difference in glycemic control between both groups was found. CGM use improved glycemic control.

  • Open Access

    Association between Systemic Lupus Erythematosus and Autoimmune Thyroid Dysfunction in Pediatric Population Cross Sectional Study, Single Center Experience

    by Radwa Shamma, Hend M. Soliman, Walaa Abdelfattah, Marwa A. Badawy, Eman S. Shafie

    Background Thyroid disease is more frequent in patients with systemic lupus erythematosus (SLE) than in the general population. The main purpose of this study is to evaluate the occurrence of immunological thyroid dysfunctions in Egyptian children with SLE in a single center and its relation to the disease activity and duration. Methods This is a cross-sectional observational study. The study included 50 children and adolescents with SLE. All patients were subjected to complete history taking, thorough physical examination. Thyroid profile, anti-thyroglobulin and anti-thyroid peroxidase antibodies were assayed using an enzyme-linked immunosorbent assay (ELISA) technique. Results Out of 50 patients, six were males (12%), and 44 were females (88%), with female to male ratio (F: M = 7: 1). Their ages ranged from 5–17 years, with a median of 12 years. Thirty-two of patients (64%) had thyroid dysfunctions, 19 (38%) were diagnosed with euthyroid sick syndrome, ten (20%) had overt hypothyroidism, three (6%) had subclinical hypothyroidism, and none of the patients had hyperthyroidism. Antithyroglobulin antibodies (Anti-TG) was normal in all patients of the studied group, and antithyroid peroxidase (anti-TPO) was elevated in one (2%) out of 50 patients. There was a significant negative correlation between free thyroxine (FT4) and disease duration with a p-value of 0.007. Moreover, by comparing the duration of the disease and thyroid antibodies (anti-TG, and anti-TPO), there was a significant negative correlation with p-values of 0.015 and 0.028. Conclusions Intermittent biochemical screening of thyroid function and anti-thyroid antibodies is recommended as part of the clinical profile in SLE patients, to identify clinical/subclinical thyroid disease. To intervene with the most convenient therapy whenever indicated.

  • Open Access

    Association between Serum Adiponectin and Insulin Resistance in Children and Adolescents with Type 1 Diabetes: A Cross-Sectional, Single Center Study from Egypt

    by Hend Soliman, Doaa Mostafa, Ahmed Helmy, Radwa Shamma

    Objective: To determine the serum level of adiponectin and its relation to insulin resistance (IR) in children and adolescents with type 1 diabetes (T1D).Materials and methods: Over a 3-month period, 65 children diagnosed with T1D who were followed up at the Diabetes Endocrine and Metabolism Pediatric Unit (DEMPU) at Cairo University Children's Hospital. Demographics, clinical data, investigations, and man-agement details were collected from the patient's medical records and evaluated for the serum level of adiponectin.Results: Mean age of the study population was 12.6 & PLUSMN; & PLUSMN; 2 years. About 40% of participants had low serum adiponectin, with a mean value of 2.4 & PLUSMN; 3.6. Sixty-one (93.8%) of participants had dyslipidemia. The mean estimated glucose disposal rate (eGDR) was 6.9 & PLUSMN; & PLUSMN; 2.1. Multivariate linear regression was performed to adjust for possible confounders in correlation between serum adiponectin and eGDR; it wasn't significant as p-value = 0.875. There was a statistically significant difference between patients with normal and low adi-ponectin regarding the age of diagnosis of diabetes, body mass index, the occurrence of microalbuminuria, and LDL level, with p-values of 0.04, 0.015, 0.022, and 0.011, respectively.Conclusions: There was also an association between lower adiponectin levels in children with type 1 diabetes and the occurrence of microalbuminuria and dyslipidemia. However, there is no reported associa-tion between its level and IR.

  • Open Access

    Antigastric parietal cell antibody as a screening test for Autoimmune gastritis in Egyptian children and adolescents with juvenile autoimmune thyroid disease and those with type 1 diabetes, single center experience

    by Ayman Emil Eskander, Nancy Samir Subhy, Walaa Abdelfattah, Radwa A. Shamma

    Purpose: The diagnosis of pediatric autoimmune gastritis (AIG) is critical due to the poor outcome and risk of malignancy. Therefore, we evaluated the prevalence of autoimmune gastritis in children with autoimmune thyroid disease (ATD) and type 1 diabetes mellitus (T1D), using parietal cell antibody (PCA) to identify its use as a screening test. Methods: PCA was measured in 90 patients; 45 patients with ATD (Hashimoto Thyroiditis and Graves' Disease) and 45 patients with T1D. Their ages ranged from 5 to 18 years. Hemoglobin, ferritin, and HbA1c (in diabetic patients) were measured. Results: PCA demonstrated a statistically significant difference between the two groups of patients with a p-value (0.024). The mean value of PCA in patients with T1D was 196.45, while it reached 148.58 in patients with ATD, with a p-value (0.003). Thirty-one (68.9%) and twelve (26.7%) of patients with T1D had high (30-200) and extremely high (> 200) values of PCA, respectively, compared to twenty-six (57.8%) and eight (17.8%) of patients with ATD who had high (30-200) and extremely high (> 200) values of PCA, respectively. Seven (87.5%) of patients with ATD with extremely high PCA( above 200) also had normocytic anemia.


  • Structural and Functional Cardiac Changes in Children with Wilson Disease

    by Magd Kotb, Fatma Al Zahraa Mostafa, Ahmad Badr, Aya Hegazy, Mohamed Samir Eid, Nahla Sabry, Radwa Shamma

    Background: Wilson disease (WD) is an autosomal recessive disease with copper overload. Its clinical picture depends on specific tissue/system damage by the excess copper. Aim of the work: We aimed to study prospectively the phenotypic spectrum of structural and functional cardiac changes among children with WD. Methods: 16 children with confirmed WD underwent electrocardiography (ECG), conventional and tissue Doppler echocardiography. Results: ECG was normal in 11 patients (68.7%), inverted T was detected in 2 (12.5%), ST elevation in 2 (12.5%) while P-pulmonale and inverted T were detected in 1 (6.25%). Five patients (31.25%) had mild and one (6.25%) had severe tricuspid regurgitation. Two girls (12.5%) with WD had underlying congenital heart defects, one had atrial septal defect (ASD) and another had double inlet left ventricle (DILV), malposed great vessels and severe pulmonary stenosis. There was a positive correlation between LV mass and duration of treatment (r=0.559, p=0.030), and a negative correlation between age of onset and LV mass index (r=0.600, p=0.018). There was no significant correlation between age of onset and duration of treatment with myocardial perfusion imaging (MPI) or tissue Doppler parameters. Conclusion: WD in children is associated with cardiac structural and functional changes including congenital structural heart malformations; ASD and DILV. Future research is needed to verify if ASD and DILV in WD are embryonic presentations of copper overload in WD.

  • Open Access

    Screening for galactosemia: is there a place for it?

    by Magd A. Kotb, Lobna Mansour, Radwa A Shamma

    Galactose is a hexose essential for production of energy, which has a prebiotic role and is essential for galactosylation of endogenous and exogenous proteins, ceramides, myelin sheath metabolism and others. The inability to metabolize galactose results in galactosemia. Galactosemia is an autosomal recessive disorder that affects newborns who are born asymptomatic, apparently well and healthy, then develop serious morbidity and mortality upon consuming milk that contains galactose. Those with galactosemia have a deficiency of an enzyme: classic galactosemia (type 1) results from severe deficiency of galactose-1-uridylyltransferase, while galactosemia type II results from galactokinase deficiency and type III results from galactose epimerase deficiency. Many countries include neonatal screening for galactosemia in their national newborn screening program; however, others do not, as the condition is rather rare, with an incidence of 1:30,000–1:100,000, and screening may be seen as not cost-effective and logistically demanding. Early detection and intervention by restricting galactose is not curative but is very rewarding, as it prevents deaths, mental retardation, liver cell failure, renal tubular acidosis and neurological sequelae, and may lead to resolution of cataract formation. Hence, national newborn screening for galactosemia prevents serious potential life-long suffering, morbidity and mortality. Recent advances in communication and biotechnology promise facilitation of logistics of neonatal screening, including improved cost-effectiveness.